Stock Analysis

High Growth Tech Stocks in Japan to Watch This August 2024

TSE:6645
Source: Shutterstock

As Japan's stock markets see modest gains amid the Bank of Japan's commitment to normalizing monetary policy, investors are keenly observing the tech sector for high-growth opportunities. In this environment, a good stock typically demonstrates strong fundamentals, innovative potential, and resilience to market fluctuations.

Top 10 High Growth Tech Companies In Japan

NameRevenue GrowthEarnings GrowthGrowth Rating
Hottolink51.80%61.94%★★★★★★
Cyber Security Cloud20.71%25.73%★★★★★☆
f-code22.70%22.62%★★★★★☆
eWeLLLtd26.52%27.53%★★★★★★
SHIFT20.25%32.08%★★★★★★
Medley24.97%30.50%★★★★★★
Kanamic NetworkLTD20.75%28.25%★★★★★★
Bengo4.comInc20.76%46.76%★★★★★★
ExaWizards22.69%62.99%★★★★★★
Money Forward20.68%66.91%★★★★★★

Click here to see the full list of 129 stocks from our Japanese High Growth Tech and AI Stocks screener.

We'll examine a selection from our screener results.

GNI Group (TSE:2160)

Simply Wall St Growth Rating: ★★★★★☆

Overview: GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally with a market cap of ¥116.89 billion.

Operations: GNI Group Ltd. focuses on the research, development, manufacture, and sale of pharmaceutical drugs across Japan and international markets. The company generates revenue through its pharmaceutical product sales while managing costs associated with research and manufacturing operations.

GNI Group's revenue is projected to grow at 28.7% annually, significantly outpacing the Japanese market's 4.3%. Earnings are forecasted to increase by 24.2% per year, with a remarkable past year's growth of 393.9%, far exceeding the biotech industry's average of 172.6%. The company recently received approval for Avatrombopag Maleate Tablets in China, adding to its lineup and enhancing its R&D pipeline focused on rare diseases.

TSE:2160 Revenue and Expenses Breakdown as at Aug 2024
TSE:2160 Revenue and Expenses Breakdown as at Aug 2024

Money Forward (TSE:3994)

Simply Wall St Growth Rating: ★★★★★★

Overview: Money Forward, Inc. offers financial solutions for individuals, financial institutions, and corporations primarily in Japan and has a market cap of ¥309.21 billion.

Operations: The company generates revenue through subscription-based services for personal finance management, cloud-based accounting software, and financial planning tools. It serves a diverse clientele including individuals, financial institutions, and corporations.

Money Forward's revenue is projected to grow at 20.7% annually, significantly outpacing Japan's market growth of 4.3%. Earnings are forecasted to increase by a robust 66.9% per year, driven by strategic initiatives such as the recent joint venture with Sumitomo Mitsui Card Company for PFM services and the transfer of its fintech business to Money Forward Kessai. Investment in R&D has been substantial, with expenses reaching ¥1.2B in the last quarter, underscoring their commitment to innovation and long-term growth potential.

TSE:3994 Revenue and Expenses Breakdown as at Aug 2024
TSE:3994 Revenue and Expenses Breakdown as at Aug 2024

OMRON (TSE:6645)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: OMRON Corporation operates globally in industrial automation, device and module solutions, social systems, and healthcare sectors with a market cap of ¥1.18 trillion.

Operations: The company's primary revenue streams are derived from its Industrial Automation Business (¥373.70 billion), Social Systems, Solutions and Service Business (¥156.85 billion), Healthcare Business (¥150.40 billion), and Devices & Module Solutions Business (¥143.69 billion). The largest contributor is the Industrial Automation sector, followed by Social Systems and Healthcare sectors in terms of revenue generation.

OMRON's recent partnership with Digimarc Corporation aims to revolutionize industrial automation, integrating digital watermarks with machine vision technology to enhance product identification and quality control. This collaboration is poised to significantly improve manufacturing efficiency and sustainability. OMRON's R&D expenses reached ¥9.8B last year, reflecting a strong commitment to innovation. The company's revenue growth is forecasted at 5.2% annually, outpacing the Japanese market average of 4.3%. Earnings are expected to grow robustly at 48.6% per year over the next three years.

TSE:6645 Revenue and Expenses Breakdown as at Aug 2024
TSE:6645 Revenue and Expenses Breakdown as at Aug 2024

Taking Advantage

Interested In Other Possibilities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com